AIBioTech provides drug discovery and diagnostic development organizations a broad range of world-class laboratory services to bring new products to market. Led by Bill Miller, CEO, Robert B. Harris, PhD, President and CSO, and Thomas Reynolds, Executive Vice President, AIBioTech is one of the world's most comprehensive Contract Research Organizations in operation. AIBioTech provides reliable expertise and cutting-edge technologies which are not available from other companies.